214 related articles for article (PubMed ID: 10602383)
1. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction.
Yu H; Eton D; Wang Y; Kumar SR; Tang L; Terramani TT; Benedict C; Hung G; Anderson WF
Gene Ther; 1999 Nov; 6(11):1876-83. PubMed ID: 10602383
[TBL] [Abstract][Full Text] [Related]
2. [High efficiency gene transfer into breast cancer cells by pseudotyped retroviral vector].
Tang LL; Yu H
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):48-50. PubMed ID: 12536615
[TBL] [Abstract][Full Text] [Related]
3. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
6. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
[TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
8. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
9. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
[TBL] [Abstract][Full Text] [Related]
10. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
11. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
12. Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector.
Eton D; Terramani TT; Wang Y; Takahashi AM; Nigro JJ; Tang L; Yu H
J Vasc Surg; 1999 May; 29(5):863-73. PubMed ID: 10231638
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
14. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
Ekhterae D; Stanley JC
J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
[TBL] [Abstract][Full Text] [Related]
16. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
17. Variable transduction efficiency of murine leukemia retroviral vector on mammalian cells: role of cellular glycosylation.
Tavoloni N; Rudenholz A
Virology; 1997 Mar; 229(1):49-56. PubMed ID: 9123877
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
19. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
Thaler S; Schnierle BS
Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells.
Yu H; Wang Y; Eton D; Stins M; Wang L; Apuzzo ML; Weaver FA; McComb JG; Weiss MH; Zlokovic BV
Neurosurgery; 1999 Oct; 45(4):962-8; discussion 968-70. PubMed ID: 10515502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]